Maximus, Inc. (MMS) Position Decreased by Janus Capital Management LLC
Janus Capital Management LLC decreased its stake in shares of Maximus, Inc. (NYSE:MMS) by 2.9% during the first quarter, Holdings Channel reports. The firm owned 2,336,364 shares of the health services provider’s stock after selling 70,407 shares during the period. Janus Capital Management LLC’s holdings in Maximus were worth $145,322,000 as of its most recent SEC filing.
Several other institutional investors have also recently modified their holdings of MMS. BlackRock Inc. raised its position in Maximus by 22,491.0% in the first quarter. BlackRock Inc. now owns 6,503,511 shares of the health services provider’s stock valued at $404,518,000 after buying an additional 6,474,723 shares during the last quarter. Vanguard Group Inc. raised its position in Maximus by 8.0% in the first quarter. Vanguard Group Inc. now owns 5,538,187 shares of the health services provider’s stock valued at $344,476,000 after buying an additional 411,521 shares during the last quarter. William Blair Investment Management LLC raised its position in Maximus by 14.7% in the first quarter. William Blair Investment Management LLC now owns 4,416,279 shares of the health services provider’s stock valued at $274,693,000 after buying an additional 566,292 shares during the last quarter. Victory Capital Management Inc. raised its position in Maximus by 14.9% in the first quarter. Victory Capital Management Inc. now owns 2,856,080 shares of the health services provider’s stock valued at $177,648,000 after buying an additional 369,794 shares during the last quarter. Finally, State Street Corp raised its position in Maximus by 2.5% in the first quarter. State Street Corp now owns 2,066,226 shares of the health services provider’s stock valued at $128,517,000 after buying an additional 50,670 shares during the last quarter. 98.67% of the stock is currently owned by institutional investors and hedge funds.
Maximus, Inc. (NYSE:MMS) traded up 0.06% during trading on Friday, reaching $63.14. The company’s stock had a trading volume of 416,332 shares. Maximus, Inc. has a 52-week low of $43.69 and a 52-week high of $64.97. The firm has a 50 day moving average price of $62.93 and a 200-day moving average price of $59.50. The stock has a market cap of $4.09 billion, a price-to-earnings ratio of 20.70 and a beta of 1.45.
Maximus (NYSE:MMS) last announced its quarterly earnings data on Thursday, May 4th. The health services provider reported $0.80 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.78 by $0.02. Maximus had a return on equity of 26.21% and a net margin of 8.18%. The company had revenue of $622 million for the quarter, compared to the consensus estimate of $620.24 million. During the same period in the previous year, the business earned $0.74 EPS. The firm’s revenue was up 2.6% compared to the same quarter last year. On average, analysts expect that Maximus, Inc. will post $3.05 earnings per share for the current year.
The business also recently disclosed a quarterly dividend, which was paid on Wednesday, May 31st. Stockholders of record on Monday, May 15th were paid a $0.045 dividend. This represents a $0.18 annualized dividend and a dividend yield of 0.29%. The ex-dividend date was Thursday, May 11th. Maximus’s dividend payout ratio (DPR) is presently 5.86%.
TRADEMARK VIOLATION WARNING: This story was posted by Watch List News and is owned by of Watch List News. If you are reading this story on another publication, it was copied illegally and reposted in violation of US and international copyright legislation. The legal version of this story can be read at https://www.watchlistnews.com/maximus-inc-mms-position-decreased-by-janus-capital-management-llc/1388710.html.
MMS has been the topic of several analyst reports. Jefferies Group LLC lowered Maximus from a “buy” rating to a “hold” rating and increased their target price for the company from $63.00 to $64.00 in a research note on Friday, May 5th. Maxim Group lowered Maximus from a “buy” rating to a “hold” rating and set a $66.00 target price on the stock. in a research note on Thursday, May 4th. They noted that the move was a valuation call. ValuEngine lowered Maximus from a “buy” rating to a “hold” rating in a research note on Tuesday, May 16th. Canaccord Genuity reissued a “buy” rating and issued a $62.00 target price on shares of Maximus in a research note on Friday, April 7th. Finally, KeyCorp reissued a “sector weight” rating on shares of Maximus in a research note on Thursday, May 25th. One equities research analyst has rated the stock with a sell rating, six have given a hold rating and one has assigned a buy rating to the company’s stock. The company presently has an average rating of “Hold” and an average target price of $61.33.
In other news, General Counsel David Francis sold 1,000 shares of the company’s stock in a transaction that occurred on Friday, May 12th. The stock was sold at an average price of $63.14, for a total value of $63,140.00. Following the completion of the transaction, the general counsel now directly owns 18,716 shares of the company’s stock, valued at $1,181,728.24. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, Director Raymond B. Ruddy sold 9,500 shares of the company’s stock in a transaction that occurred on Thursday, March 30th. The shares were sold at an average price of $62.53, for a total value of $594,035.00. Following the completion of the transaction, the director now directly owns 286,052 shares of the company’s stock, valued at $17,886,831.56. The disclosure for this sale can be found here. Over the last three months, insiders sold 121,846 shares of company stock valued at $7,645,191. Company insiders own 3.10% of the company’s stock.
Maximus Company Profile
MAXIMUS, Inc provides business process services (BPS) to government health and human services agencies. The Company operates through three segments: U.S. Federal Services, Health Services and Human Services. The U.S. Federal Services segment provides BPS and program management for large government programs, independent health review and appeals services for both the United States Federal Government, and state-based programs and technology solutions for civilian federal programs.
Want to see what other hedge funds are holding MMS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Maximus, Inc. (NYSE:MMS).
Receive News & Ratings for Maximus Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Maximus Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.